Mass General Brigham Incorporated
- Assets
- $81.6m
- Revenue
- $28.8m
- Investments
- $2.2m
- Employees
- 178
- Location
- Boston, MA
- Founding
- 11/2010
- Data as of
- 09/2018
- EIN
- 04-2129889
Organization Overview
Mass General Brigham Incorporated is located in Boston, MA. The organization was established in 2010. According to its NTEE Classification (E21) the organization is classified as: Community Health Systems, under the broad grouping of Health Care and related organizations. As of 09/2018, Mass General Brigham Incorporated employed 178 individuals. This organization is a subordinate organization within an affiliated group for tax-exemption purposes. Mass General Brigham Incorporated is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2018, Mass General Brigham Incorporated generated $28.8m in total revenue. This organization has experienced exceptional growth, as over the past 3 years, it has increased revenue by an average of 10.4% each year . All expenses for the organization totaled $28.9m during the year ending 09/2018. While expenses have increased by 5.3% per year over the past 3 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2018
Describe the Organization's Mission:
Part 3 - Line 1
SEE SCHEDULE O.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE INSTITUTE HAS RESEARCH AT EVERY STAGE OF DEVELOPMENT FROM THE CRITICAL NEW IDEAS THAT ARE CHANGING THE WAY RESEARCHERS AROUND THE WORLD LOOK AT THE FUTURE OF TREATMENT, TO PRODUCTS IN LATE-STAGE CLINICAL TRIALS, SET TO MAKE AN IMMEDIATE IMPACT ON THE LIVES OF PEOPLE STRUGGLING WITH VISION-ROBBING DISEASES AND INJURIES. THE INSTITUTE HAS MADE TREMENDOUS PROGRESS IN DEVELOPING NEW CURES FOR MACULAR DEGENERATION, DIABETIC RETINOPATHY, GLAUCOMA, OTHER TYPES OF RETINAL AND OPTIC NERVE DEGENERATIONS AND DAMAGE, DRY EYE AND EYE TISSUE TRANSPLANTS. THERE HAVE ALSO BEEN GREAT STRIDES MADE IN THE DEVELOPMENT OF NEW TECHNOLOGIES - NEW LENSES AND DEVICES - TO HELP THOSE WITH LOW VISION MAKE THE ABSOLUTE MOST OUT OF THE VISION THEY HAVE UNTIL WE CAN REVERSE VISION LOSS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Mark Abelson Director (until 12/17) | Trustee | 4 | $0 |
William Aikman Director | Trustee | 4 | $0 |
Dewalt Pete Ankeny Director | Trustee | 4 | $0 |
Kennett Burnes Chairman | OfficerTrustee | 4 | $0 |
Charles DE Gunzberg Director | Trustee | 4 | $0 |
John Fernandez President | OfficerTrustee | 4 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $755,749 |
| Government grants | $18,015,403 |
| All other contributions, gifts, grants, and similar amounts not included above | $2,622,343 |
| Noncash contributions included in lines 1a–1f | $31,519 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $21,393,495 |
| Total Program Service Revenue | $2,000,156 |
| Investment income | $369,593 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $365,780 |
| Net Rental Income | $170,696 |
| Net Gain/Loss on Asset Sales | $3,663,379 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $28,772,720 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $228,372 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $410,856 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $12,999,146 |
| Pension plan accruals and contributions | $872,285 |
| Other employee benefits | $2,508,781 |
| Payroll taxes | $681,988 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $13,143 |
| Fees for services: Accounting | $33,282 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $43,532 |
| Fees for services: Other | $545,768 |
| Advertising and promotion | $24,904 |
| Office expenses | $4,069,225 |
| Information technology | $296,363 |
| Royalties | -$14,841 |
| Occupancy | $3,647,324 |
| Travel | $346,497 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $101,225 |
| Interest | $346,646 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $1,045,381 |
| Insurance | $77,829 |
| All other expenses | $0 |
| Total functional expenses | $28,869,943 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $5,659,887 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $4,986,003 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $18,183 |
| Net Land, buildings, and equipment | $17,671,294 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $2,187,605 |
| Investments—program-related | $0 |
| Intangible assets | $768,476 |
| Other assets | $50,270,918 |
| Total assets | $81,562,366 |
| Accounts payable and accrued expenses | $842,613 |
| Grants payable | $0 |
| Deferred revenue | $5,844,819 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $57,712,107 |
| Total liabilities | $64,399,539 |
| Unrestricted restricted net Assets | -$2,679,718 |
| Temporarily restricted net Assets | $7,830,827 |
| Permanently restricted net Assets or current funds | $12,011,718 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Total net assets or fund balances | $17,162,827 |
Grants Awarded
Over the last fiscal year, Mass General Brigham Incorporated has awarded $228,371 in support to 6 organizations.
| Grant Recipient | Amount |
|---|---|
DUKE UNIVERSITY PURPOSE: RESEARCH | $34,944 |
BOSTON CHILDREN'S HOSPITAL PURPOSE: RESEARCH | $51,478 |
TUFTS UNIVERSITY PURPOSE: RESEARCH | $12,152 |
UNIVERSITY OF NEBRASKA MEDICAL CENTER PURPOSE: RESEARCH | $49,795 |
UNIVERSITY OF PITTSBURGH PURPOSE: RESEARCH | $12,109 |
METIS FOUNDATION PURPOSE: RESEARCH | $67,893 |